<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02864017</url>
  </required_header>
  <id_info>
    <org_study_id>35RC14_9835</org_study_id>
    <secondary_id>2015-A00961-48</secondary_id>
    <nct_id>NCT02864017</nct_id>
  </id_info>
  <brief_title>Immuno Nutrition by L-citrulline for Critically Ill Patients</brief_title>
  <acronym>Immunocitre</acronym>
  <official_title>Immuno Nutrition by L-citrulline for Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to demonstrate that the only administration of
      L-citrulline, can improve immune functions in critically ill patients at high risk of
      nosocomial infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicentric therapeutic trial, randomized and double blind: standard enteral
      nutrition plus L-citrulline (5 grams/12 Hours for 5 days from the admission in Intensive Care
      Unit (ICU)) versus standard enteral nutrition plus placebo.

      Methods-Patients: Non-surgical patients admitted in medical intensive care unit, under
      mechanical ventilation for an expected duration &gt; 2 days, without severe sepsis or septic
      shock, will be enrolled. Symptoms leading for ICU admission ongoing for five days maximum. On
      admission (before treatment), the severity will be evaluated with the Sepsis-related Organ
      Failure Assessment (SOFA) score together with an assessment of plasmatic arginine, cytokines
      (InterLeukin-6 (IL6) ), and expression of Human Leukocyte Antigen - antigen D Related
      (HLA-DR) by monocytes. The same evaluation will be repeated on day 3 (during treatment) and
      on day 7 (after treatment).

      The enrolment of 100 patients is statistically enough to demonstrate a decreased SOFA scores
      in the L-citrulline group as compared to the placebo group on day 7.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Organ failure score comparison D7</measure>
    <time_frame>At day 7</time_frame>
    <description>Organ failure score (SOFA score) on day 7 in the L-citrulline group as compared to the placebo group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Organ failure score comparison D3</measure>
    <time_frame>At day 3</time_frame>
    <description>Organ failure score (SOFA score) on day 3 in the L-citrulline group as compared to the placebo group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score evolution between randomisation and D7</measure>
    <time_frame>up to 7 days</time_frame>
    <description>Binary criterion of success or failure :
- Success is defined by: an improved SOFA score of at least 2 points from randomization to Day 7 or an improvement in the general condition yielding the release of the unit;
- Failure is defined by an improved SOFA score but less than 2 points, no improvement or worsening of the SOFA score from randomization to Day 7 or the patient's death before J7;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of HLA-DR</measure>
    <time_frame>At day 7</time_frame>
    <description>Expression of HLA-DR in the L-citrulline group as compared to the placebo group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasmatic concentration of IL6</measure>
    <time_frame>At day 7</time_frame>
    <description>Comparison of the plasmatic concentration of interleukin-6 between the L-citrulline group and the placebo group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HLA-DR</measure>
    <time_frame>At day 7</time_frame>
    <description>Comparison of the percentage of expression of monocytic HLA-DR between the L-citrulline group and the placebo group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasmatic concentration of L-arginine</measure>
    <time_frame>At day 7</time_frame>
    <description>Comparison of the plasmatic concentration of L-arginine and its metabolites between the L-citrulline group and the placebo group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of nosocomial infections</measure>
    <time_frame>during the stay in the ICU, an average of 7 days</time_frame>
    <description>Comparison between the L-citrulline group and the placebo group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>during the stay in hospital, up to 28 days</time_frame>
    <description>Length of stay in ICU and hospital: Comparison between the L-citrulline group and the placebo group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>during the stay in hospital, up to 28 days</time_frame>
    <description>Mortality in intensive care and in hospital : Comparison between the L-citrulline group and the placebo group
Duration of mechanical ventilation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>during the stay in ICU, an average of 7 days</time_frame>
    <description>Duration of mechanical ventilation: Comparison between the L-citrulline group and the placebo group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Intubation</condition>
  <condition>Pulmonary Ventilation</condition>
  <arm_group>
    <arm_group_label>L-Citrulline group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Enteral nutrition 5-day L-citrulline treatment (10 grams/day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Enteral nutrition 5-day placebo treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Enteral nutrition</intervention_name>
    <arm_group_label>L-Citrulline group</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>L-Citrulline</intervention_name>
    <arm_group_label>L-Citrulline group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 years

          -  medical patient (absence of recent surgery or trauma)

          -  initial aggression &lt; 5 days

          -  mechanically ventilated with expected duration of mechanical ventilation &gt; 2 days

          -  exclusive enteral nutrition

          -  absence of previous immunosuppression

        Exclusion Criteria:

          -  severe sepsis

          -  septic shock

          -  obesity defined as BMI above 40

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Marc TADIE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Rennes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Marc TADIE, MD</last_name>
    <email>jean-marc.tadie@chu-rennes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rennes Hospital University</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Marc TADIE, MD</last_name>
      <email>jean-marc.tadie@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Marc TADIE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2016</study_first_submitted>
  <study_first_submitted_qc>August 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2016</study_first_posted>
  <last_update_submitted>November 10, 2017</last_update_submitted>
  <last_update_submitted_qc>November 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

